Search - tctmd.com

Displaying 81 - 100 of 174

Sort: Relevancy | Date

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Todd Neale

December 14, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Shelley Wood

October 20, 2021

News Daily News

FDA Investigating Possible Sex Differences in LAAO Outcomes

Todd Neale

September 27, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2021

Shelley Wood

September 03, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News

LVADs Can Be ‘Transformational’ for Elderly HF Patients

Caitlin E. Cox

August 25, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Conference News ESC Heart Failure 2021

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

Shelley Wood

June 30, 2021

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

Todd Neale

May 18, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

Advertisement

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

March 2022 News Roundup

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

February 2022 News Roundup

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

January 2022 News Roundup

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

FDA Investigating Possible Sex Differences in LAAO Outcomes

TCTMD’s Top 10 Most Popular Stories for August 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

LVADs Can Be ‘Transformational’ for Elderly HF Patients

July/August 2021 News Roundup

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

‘Enormous’ QoL Improvements With Mavacamten in HCM

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content